- Home
- ETON vs CMCO Comparison
ETON vs CMCO Comparison
Compare ETON & CMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- CMCO
- Stock Information
- Founded
- ETON 2017
- CMCO 1875
- Country
- ETON United States
- CMCO United States
- Employees
- ETON N/A
- CMCO N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- CMCO Construction/Ag Equipment/Trucks
- Sector
- ETON Health Care
- CMCO Industrials
- Exchange
- ETON Nasdaq
- CMCO Nasdaq
- Market Cap
- ETON 388.3M
- CMCO 430.3M
- IPO Year
- ETON 2018
- CMCO 1996
- Fundamental
- Price
- ETON $17.68
- CMCO $14.81
- Analyst Decision
- ETON Strong Buy
- CMCO Hold
- Analyst Count
- ETON 3
- CMCO 1
- Target Price
- ETON $29.67
- CMCO $35.00
- AVG Volume (30 Days)
- ETON 206.2K
- CMCO 307.1K
- Earning Date
- ETON 11-11-2025
- CMCO 10-29-2025
- Dividend Yield
- ETON N/A
- CMCO 1.90%
- EPS Growth
- ETON N/A
- CMCO N/A
- EPS
- ETON N/A
- CMCO N/A
- Revenue
- ETON $58,181,000.00
- CMCO $959,221,000.00
- Revenue This Year
- ETON $105.25
- CMCO $2.95
- Revenue Next Year
- ETON $40.84
- CMCO $4.09
- P/E Ratio
- ETON N/A
- CMCO N/A
- Revenue Growth
- ETON 85.40
- CMCO N/A
- 52 Week Low
- ETON $5.35
- CMCO $11.78
- 52 Week High
- ETON $21.48
- CMCO $41.05
- Technical
- Relative Strength Index (RSI)
- ETON 59.16
- CMCO 50.28
- Support Level
- ETON $17.24
- CMCO $14.34
- Resistance Level
- ETON $18.52
- CMCO $14.93
- Average True Range (ATR)
- ETON 0.66
- CMCO 0.55
- MACD
- ETON -0.07
- CMCO 0.02
- Stochastic Oscillator
- ETON 54.10
- CMCO 38.07
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About CMCO Columbus McKinnon Corporation
Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.